Overview of Dr. Diamond
Dr. Eli Diamond is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 10 years. He is one of 63 doctors at Memorial Sloan Kettering Cancer Center and one of 6 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Neurology. He has more than 100 publications and over 500 citings.
Office
160 East 53rd Street
New York, NY 10022
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2008 - 2011
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2007 - 2008
Albert Einstein College of MedicineClass of 2007
Certifications & Licensure
FL State Medical License 2022 - Present
NJ State Medical License 2022 - 2025
NY State Medical License 2011 - 2024
NC State Medical License 2020 - 2022
MA State Medical License 2009 - 2012- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Prognostic Awareness and Patient-Physician Communication in Malignant Glioma Start of enrollment: 2013 Dec 01
- Long-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester Disease Start of enrollment: 2014 Mar 01
- Single-agent Cobimetinib for Adults With Histiocytic Disorders Start of enrollment: 2016 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsMulti-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics.Kee Kiat Yeo, Sanda Alexandrescu, Jennifer A Cotter, Jayne Vogelzang, Varun Bhave
Neuro-Oncology. 2023-01-05 - 188 citationsErdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular eraGaurav Goyal, Mark L. Heaney, Matthew Collin, Fleur Cohen-Aubart, Augusto Vaglio
Blood. 2020-05-28 - 28 citationsHistiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.Ronald S. Go, Eric D. Jacobsen, Robert A. Baiocchi, Ilia Buhtoiarov, Erin Butler
Journal of the National Comprehensive Cancer Network. 2021-11-01
Press Mentions
FDA Approves First Treatment for Patients with All Forms of HistiocytosisJanuary 30th, 2023
High Response Rate in Histiocytic Disease with MEK InhibitionJanuary 3rd, 2018
NCCN Foundation Awards Grants to Five Young InvestigatorsApril 1st, 2016
